Biolinerx (BLRX) Reports Q3 Loss of NIS 0.15

November 14, 2012 7:02 AM

Biolinerx (NASDAQ: BLRX) reported Q3 EPS of NIS (0.15), versus NIS (0.06) reported last year.

For earnings history and earnings-related data on Biolinerx (BLRX) click here.

No results found